Abstract
Naphthyridine 7 inhibits the strand transfer of the integration process catalyzed by integrase with an IC50 of 10 nM and inhibits 95% of the spread of HIV-1 infection in cell culture at 0.39 microM. It does not exhibit cytotoxicity in cell culture at < or =12.5 microM and shows a good pharmacokinetic profile when dosed orally to rats. The antiviral activity of 7 and its effect on integration were confirmed using viruses with specific integrase mutations.
MeSH terms
-
Administration, Oral
-
Animals
-
Anti-HIV Agents / chemical synthesis*
-
Anti-HIV Agents / chemistry
-
Anti-HIV Agents / pharmacology
-
Cell Line
-
HIV Integrase Inhibitors / chemical synthesis*
-
HIV Integrase Inhibitors / chemistry
-
HIV Integrase Inhibitors / pharmacology
-
HIV-1 / drug effects*
-
Humans
-
Injections, Intravenous
-
Naphthyridines / chemical synthesis*
-
Naphthyridines / chemistry
-
Naphthyridines / pharmacology
-
Rats
-
Structure-Activity Relationship
Substances
-
Anti-HIV Agents
-
HIV Integrase Inhibitors
-
Naphthyridines